Cardio 365 - introductory page
not logged  
Change language:    

EVALUATION OF CARDIOVASCULAR HIGH RISK POPULATION IN SPECIALISTS AMBULANCE - ESA

J. Žižka, M. Souček (Praha, Brno)
Topic: Hypertension
Type: Poster - doctors, 18th CSC Annual Congress

Background: Arterial hypertension is the most prevalent CV disease in the Czech Republic with estimated prevalence 35% among population aged 25 to 64 years.
Although serious public health problem with significant medical and economic consequences the treatment of HT is currently unsatisfactory. Only 18.4 % of patients with arterial HT reach goal BP. Aim: To obtain following data from the specialists ambulances (internists and cardiologists) regarding hypertensive patients: frequency of high risk hypertensive patients and proportion of patients with hypertension in whom BP is well controlled (target BP reached).Other goal of the study was to obtain data about pharmacological treatment of hypertensive patients.
Method: National, multicenter, non-interventional, cross sectional, representative sample, one visit study.
Results: Data of 19821 patients with primary hypertension visited office-based internists and cardiologists was analysed. The average age was 64± 12 years (range 19-99 years), 53% was women. The mean blood pressure of entire population was 138,5±15,1/81,7±9,1 mmHg.  There were high proportion of pateints with well controlled blood pressure (BP below 140/90 mmHg) – 48% of the patients. Among those with diabetes the proportion of well controlled patients was lower–11% of the patients. Regrding other CV risk factors the most common was hyperlipidaemia–66% of the patients, following by diabetes and smoking with 29 and 14% of the patients. 8.444 (43%) of the patients suffered from the coronary artery diseases, 2.251 (11%) patients have experienced stroke or TIA and 1.601 (8%) patients had peripheral artery disease. Regarding antihypertensive therapy, only 21% of the populaton was treated by monotherapy. The most common was the combination of ACE inhibitors plus diuretics or triple-combination of ACE inhibitors plus diuretics plus beta-blockers.